Shanxi C&Y Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -27.13% vs 24.67% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -75.08% vs 1,206.90% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "173.80",
          "val2": "238.50",
          "chgp": "-27.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.00",
          "val2": "43.10",
          "chgp": "-79.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "5.70",
          "chgp": "-7.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.00",
          "val2": "32.10",
          "chgp": "-75.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.50%",
          "val2": "180.70%",
          "chgp": "-12.92%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.01% vs -3.69% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 53.59% vs 149.74% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "838.00",
          "val2": "790.50",
          "chgp": "6.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "121.90",
          "val2": "87.00",
          "chgp": "40.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.10",
          "val2": "33.30",
          "chgp": "-48.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.30",
          "val2": "-4.60",
          "chgp": "6.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "74.80",
          "val2": "48.70",
          "chgp": "53.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "74.80%",
          "val2": "35.00%",
          "chgp": "3.98%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Sep'25

Change(%)

Net Sales

173.80

238.50

-27.13%

Operating Profit (PBDIT) excl Other Income

9.00

43.10

-79.12%

Interest

5.30

5.70

-7.02%

Exceptional Items

0.00

0.00

Consolidate Net Profit

8.00

32.10

-75.08%

Operating Profit Margin (Excl OI)

51.50%

180.70%

-12.92%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -27.13% vs 24.67% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -75.08% vs 1,206.90% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

838.00

790.50

6.01%

Operating Profit (PBDIT) excl Other Income

121.90

87.00

40.11%

Interest

17.10

33.30

-48.65%

Exceptional Items

-4.30

-4.60

6.52%

Consolidate Net Profit

74.80

48.70

53.59%

Operating Profit Margin (Excl OI)

74.80%

35.00%

3.98%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 6.01% vs -3.69% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 53.59% vs 149.74% in Dec 2023

All Annual Results